Skip to Content

Prescription drug reporting due for employer-sponsored health plans

December 6, 2022 Article 1 min read
Authors:
Scott McLellan Jonathon Trionfi
New CAA transparency provision requires employer-sponsored health plans and health insurance issuers to report information about prescription drugs and healthcare spending by Dec. 27, 2022.
Front of U.S. government building.Enacted as part of the 2021 Consolidated Appropriations Act, a new transparency provision now requires employer-sponsored health plans and health insurance issuers to submit information about prescription drugs and healthcare spending to the federal government on an annual basis. This reporting process is referred to as the “prescription drug data collection” (or RxDC report).

The first RxDC report is due by Dec. 27, 2022, and covers data for the 2020 and 2021 reference years. Subsequent reports are due June 1 every year after. 

Download the bulletin to learn how the RxDC reporting requirement impacts employers, access reporting instructions, and identify next steps for your organization. For questions on your organization’s specific reporting process, please contact Plante Moran Group Benefit Advisors.

This Legal Update is not intended to be exhaustive nor should any discussion or opinions be construed as legal advice. Readers should contact legal counsel for legal advice. ©2022 Zywave, Inc. All rights reserved.

Related Thinking

Business professionals meeting in a conference room.
Nov. 29-Dec. 7, 2022

2022 Year-End Webinar Series

Webinar
Businessman using a laptop computer.
September 26, 2022

Penalty increase for employers who fail to comply with ACA “pay or play” rules

Article 1 min read
Professional walking up steps
June 28, 2022

TiC Final Rules requirement: Plans and insurers must provide price comparison tool

Article 1 min read